Physician profile
Sandra De Roldan
NPI 1235479627
$756.15
in general payments reported to CMS, 2019-2025
8 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.12 · 2022: $32.30 · 2023: $200 · 2024: $300 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $217.78 | 2021-2025 | |
| Dexcom, INC. | $116.69 | 2023 | Dexcom G7 Gss (161) |
| Boston Scientific Corporation | $114.44 | 2022-2025 | Watchman Flx, General - Pain Management |
| Kiniksa Pharmaceuticals International, Plc | $100.97 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $89.63 | 2023-2025 | Shingrix, Bexsero, Arexvy |
| Hologic Sales and Service, LLC | $74.46 | 2024 | Aptima |
| Lilly USA, LLC | $24.18 | 2023 | Mounjaro, Trulicity |
| Medtronic, INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra De Roldan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.